The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
Open accessAbstract
We have recently described GS 4071, a carbocyclic transition-state analog inhibitor of the influenza virus neuraminidase, which has potent inhibitory activity comparable to that of 4-guanidino-Neu5Ac2en (GG167; zanamivir) when tested against influenza A virus replication and neuraminidase activity in vitro. We now report that GS 4071 is active against several strains of influenza A and B viruses in vitro and that oral GS 4104, an ethyl ester prodrug which is converted to GS 4071 in vivo, is active in the mouse and ferret models of influenza virus infection. Oral administration of 10 mg of GS 4104 per kg of body weight per day caused a 100-fold reduction in lung homogenate viral titers and enhanced survival in mice infected with influenza A or B viruses. In ferrets, a 25-mg/kg dose of GS 4104 given twice daily reduced peak viral titers in nasal washings and eliminated constitutional responses to influenza virus infection including fever, increased nasal signs (sneezing, nasal discharge, mouth breathing), and decreased activity. Consistent with our demonstration that the parent compound is highly specific for influenza virus neuraminidases, no significant drug-related toxicity was observed after the administration of oral dosages of GS 4104 of up to 800 mg/kg/day for 14 days in nonclinical toxicology studies with rats. These results indicate that GS 4104 is a novel, orally active antiviral agent with the potential to be used for the prophylaxis and treatment of influenza A and B virus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The determination of enzyme inhibitor constants
Dixon, M. (1953) · Biochemical Journal · doi:10.1042/bj0550170 · Cited by 4,069
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Self-citationPotier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 815
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 789
Hayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762
Options for the control of influenza III
Ada, G. L., Tannock, G. A., & Hampson, A. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00191-0 · Cited by 587
Varghese, J. N., McKimm‐Breschkin, J. L., Caldwell, J. B., Kortt, A. A., & Colman, P. M. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340140302 · Cited by 402
Liu, C., Eichelberger, M. C., Compans, R. W., & Air, G. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1099-1106.1995 · Cited by 367
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.
Lui, K. J., & Kendal, A. P. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.712 · Cited by 319
Burmeister, W. P., Ruigrok, R. W., & Cusack, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05026.x · Cited by 314
The Molecular Biology of Influenza Virus Pathogenicity
Klenk, H.-D., & Rott, R. (1988) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60520-5 · Cited by 313
Woods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D. M., Ticehurst, J., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312
Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden, F. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530280047035 · Cited by 291
Plaque inhibition assay for drug susceptibility testing of influenza viruses
Hayden, F. G., Cote, K. M., & Douglas, R. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.5.865 · Cited by 278
Colman, P. M., Hoyne, P. A., & Lawrence, M. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.2972-2980.1993 · Cited by 255
Emergence and Transmission of Influenza A Viruses Resistant to Amantadine and Rimantadine
Hayden, F. G., & Hay, A. J. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-77011-1_8 · Cited by 239
Li, W., Escarpe, P. A., Eisenberg, E. J., Cundy, K. C., Sweet, C., Jakeman, K. J., Merson, J., Lew, W., Williams, M., Zhang, L., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.647 · Cited by 223
Self-citationTaylor, N. R., & von Itzstein, M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a011 · Cited by 203
CHONG, A. K. J., PEGG, M. S., TAYLOR, N. R., & von ITZSTEIN, M. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17055.x · Cited by 178
Sidwell, R. W., Huffman, J. H., Barnard, D. L., Bailey, K. W., Wong, M.-H., Morrison, A., Syndergaard, T., & Kim, C. U. (1998) · Antiviral Research · doi:10.1016/s0166-3542(97)00065-x · Cited by 170
Self-citationvon Itzstein, M., Wu, W.-Y., & Jin, B. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84065-2 · Cited by 148
Ryan, D., Ticehurst, J. R., Dempsey, M. H., & Penn, C. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2270 · Cited by 144
Assessment of signs of influenza illness in the ferret model
Reuman, P. D., Keely, S., & Schiff, G. M. (1989) · Journal of Virological Methods · doi:10.1016/0166-0934(89)90004-9 · Cited by 138
Effects of Low- and High-Passage Influenza Virus Infection in Normal and Nude Mice
Wyde, P. R., Couch, R. B., Mackler, B. F., Cate, T. R., & Levy, B. M. (1977) · Infection and Immunity · doi:10.1128/iai.15.1.221-229.1977 · Cited by 121
Ryan, D., Ticehurst, J. R., & Dempsey, M. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2583 · Cited by 93
MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION
Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.38 · Cited by 93
Eisenberg, E. J., Bidgood, A. M., & Cundy, K. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1949 · Cited by 87
Soriano, F. G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.647 · Cited by 80
Toms, G. L., Davies, J. A., Woodward, C. G., Sweet, C. R., & Smith, H. C. (1977) · PubMed · Cited by 79
Self-citationMUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION
Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.39 · Cited by 63
Sollis, S. L., Smith, P. W., Howes, P. D., Cherry, P. C., & Bethell, R. C. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00318-6 · Cited by 55
Hayden, F. G., Rollins, B. S., & Madren, L. K. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90101-5 · Cited by 53
Thomas, G. P., Forsyth, M. A., Penn, C. R., & McCauley, J. W. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90081-7 · Cited by 50
Colman, P. M. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0811-9_4 · Cited by 48
Effect of selenazofurin on influenza A and B virus infections of mice
Sidwell, R. W., Huffman, J. H., Call, E., Alaghamandan, H. A., Cook, P. D., & Robins, R. K. (1986) · Antiviral Research · doi:10.1016/0166-3542(86)90016-1 · Cited by 37
Self-citationGreffard, A., Pairon, J. ‐., Terzidis-Trabelsi, H., Heslan, J., Bignon, J., Lambré, C., & Pilatte, Y. (1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90106-6 · Cited by 9
Cited by
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Abdul-Aziz, M. H., Alffenaar, J.-W. C., Bassetti, M., Bracht, H., Dimopoulos, G., Marriott, D., Neely, M. N., Paiva, J.-A., Pea, F., Sjovall, F., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06050-1 · Cited by 1,081
Treanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R. G., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,014
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Nicholson, K., Aoki, F., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, C., Rode, A., Kinnersley, N., & Ward, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02288-1 · Cited by 785
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Influenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
Metadata
- Authors
- Mendel, D. B., Tai, C. Y., Escarpe, P. A., Li, W., Sidwell, R. W., Huffman, J. H., Sweet, C., Jakeman, K. J., Merson, J., Lacy, S. A., Lew, W., Williams, M. A., Zhang, L., Chen, M. S., Bischofberger, N., & Kim, C. U.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-03
- Volume
- 42
- Issue
- 3
- Pages
- 640-646
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2126383827
- Cited by
- 255
- References
- 37
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.